# Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer

> **NCT00759226** · PHASE2 · COMPLETED · sponsor: **CONKO-Studiengruppe** · enrollment: 92 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Cisplatin
- **DRUG:** 5-FU
- **DRUG:** Folinic Acid

## Key facts

- **NCT ID:** NCT00759226
- **Lead sponsor:** CONKO-Studiengruppe
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2005-07
- **Final completion:** 2007-08
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2008-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759226, "Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00759226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*